Berbamine targets cancer stem cells and reverses cabazitaxel resistance via inhibiting IGF2BP1 and p-STAT3 in prostate cancer.

Lili WangChen LyuBirgit StadlbauerAlexander BuchnerElfriede NößnerHeike Pohla

Published in: The Prostate (2023)

Berbamine enhanced the toxic activity of cabazitaxel and reversed cabazitaxel resistance potentially through CXCR4/exosomal let-7/IGF2BP1 and ABCG2/exosomal miR-26b/p-STAT3 axes.

Keyphrases

cancer stem cells
prostate cancer
cell proliferation
pi k akt
radical prostatectomy
signaling pathway
binding protein
growth hormone